Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients
Purpose of Review
Older adults with cancer have complex medical needs and often experience higher rates of treatment-related toxicities compared to their younger counterparts. The advent of health information technologies can address multiple gaps in the care of this population. We review the role of existing and emerging technologies in facilitating the use of comprehensive geriatric assessment (CGA) in routine clinics, promoting symptom reporting, and monitoring medication adherence.
Increasingly, studies demonstrate the feasibility of implementing electronic CGA in routine oncology practices. Evidence also suggests that electronic symptom reporting can improve outcomes in patients with cancer. In addition, technology devices can be used to promote adherence to cancer therapy.
There are many opportunities for information technology to be integrated into the management and treatment of older adults with cancer. However, further evaluation of these technologies is needed to ensure that they meet the needs of the targeted end users.
KeywordsInformation technology Symptom monitoring Medication adherence Geriatric assessment
The work was funded through a Patient-Centered Outcomes Research Institute (PCORI) Program contract (4634), UG1 CA189961 from the National Cancer Institute, and R01 CA177592 from the National Cancer Institute as well as the Wilmot Research Fellowship Award and National Cancer Institute R25 CA102618. This work was made possible by the generous donors to the WCI geriatric oncology philanthropy fund.
Compliance with Ethical Standards
Conflict of Interest
Kah Poh Loh, Colin McHugh, Supriya G. Mohile, Karen Mustian, Marie Flannery, Heidi Klepin, Rebecca Schnall, Eva Culakova, and Erika Ramsdale declare they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc. 2006;117:147–56.Google Scholar
- 5.Loh KP, Janelsins MC, Mohile SG, Holmes HM, Hsu T, Inouye SK, et al. Chemotherapy-related cognitive impairment in older patients with cancer. J Geriatr Oncol. 2016;7(4):270–80. https://doi.org/10.1016/j.jgo.2016.04.008.
- 6.Karuturi M, Wong ML, Hsu T, Kimmick GG, Lichtman SM, Holmes HM, et al. Understanding cognition in older patients with cancer. J Geriatr Oncol. 2016;7(4):258–69. https://doi.org/10.1016/j.jgo.2016.04.004.
- 7.Herrera AP, Snipes SA, King DW, Torres-Vigil I, Goldberg DS, Weinberg AD. Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change. Am J Public Health. 2010;100(S1):S105–12. https://doi.org/10.2105/AJPH.2009.162982.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Loh KP, Soto-Perez-de-Celis E, Hsu T, de Glas NA, Battisti NML, Capucine B, et al. What every oncologist should know about geriatric assessment for older patients with cancer: Young SIOG position paper. J Oncol Pract. 2018. (in press).Google Scholar
- 9.Hurria A, Gupta S, Zauderer M, Zuckerman EL, Cohen HJ, Muss H, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005;104(9):1998–2005. https://doi.org/10.1002/cncr.21422.
- 11.Brody EM, Kleban MH. Physical and mental health symptoms of older people: who do they tell? J Am Geriatr Soc. 1981;29(10):442–9. https://doi.org/10.1111/j.1532-5415.1981.tb01746.x.CrossRefPubMedGoogle Scholar
- 13.Bender CM, Gentry AL, Brufsky AM, Casillo FE, Cohen SM, Dailey MM, et al. Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer. Oncol Nurs Forum. 2014;41(3):274–85. https://doi.org/10.1188/14.ONF.274-285.
- 15.The National Comprehensive Cancer Network®. 2015. Older adult oncology: NCCN guidelines. [ONLINE] Available at: http://www.nccn.org/professionals/physician_gls/pdf/senior.pdf. [Accessed 09 January 16].
- 16.Pew Research Center. Americans’ Internet AccessL 2000-2015. 2015 June. Available at: http://www.pewinternet.org/2015/06/26/americans-internet-access-2000-2015/.
- 20.Karnofsky D, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949. p. 191–205.Google Scholar
- 21.Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55. https://doi.org/10.1097/00000421-198212000-00014.
- 22.Puts MTE, Monette J, Girre V, Pepe C, Monette M, Assouline S, et al. Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study. Crit Rev Oncol Hematol. 2011;78(2):138–49. https://doi.org/10.1016/j.critrevonc.2010.04.003.
- 26.• Elliot K, Tooze JA, Geller R, Powell BL, Pardee TS, Ritchie E, et al. The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML). Leuk Res. 2014;38:1184–90. Polypharmacy is common and associated with higher mortality in older patients with AML. Google Scholar
- 28.Soubeyran P, Bellera C, Goyard J, Heitz D, Curé H, Rousselot H, et al. Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study. PLoS One. 2014;9(12):e115060. https://doi.org/10.1371/journal.pone.0115060.
- 31.Neuman HB, Weiss JM, Leverson G, O’Connor ES, Greenblatt DY, LoConte NK, et al. Predictors of short-term post-operative survival after elective colectomy in colon cancer patients ≥80 years of age. Ann Surg Oncol. 2013;20(5):1427–35. https://doi.org/10.1245/s10434-012-2721-8.
- 32.Courtney-Brooks M, Tellawi AR, Scalici J, Duska LR, Jazaeri AA, Modesitt SC, et al. Frailty: an outcome predictor for elderly gynecologic oncology patients. Gynecol Oncol. 2012;126(1):20–4. https://doi.org/10.1016/j.ygyno.2012.04.019.
- 33.• Loh KP, Magnuson A, Dale W, et al. Association of patient age, function and cognition with cancer treatment decisions: a University of Rochester NCORP study. J Clin Oncol. 2016;34. https://doi.org/10.1200/JCO.2016.34.15_suppl.10038. Low percentage of community oncologists utilized a geriatric assessment in routine practice.
- 34.Mohile S, Magnuson S, Pandya C, Velarde C, Duberstein P, Hurria A, et al. Community Oncologists’ Decision-Making For Treatment of Older Patients with Cancer. J Natl Compr Canc Netw. 2018. (in press).Google Scholar
- 35.Hurria A, Cirrincione CT, Muss HB, Kornblith AB, Barry W, Artz AS, et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol. 2011;29(10):1290–6. https://doi.org/10.1200/JCO.2010.30.6985.
- 36.•• Hurria A, Akiba C, Kim J, et al. Reliability, validity, and feasibility of a computer-based geriatric assessment for older adults with cancer. J Oncol Pract. 2016;12:e1025–34. Computer-based geriatric assessment is feasible in the geriatric oncology population. CrossRefPubMedPubMedCentralGoogle Scholar
- 37.• Bhatt G, Hofmeister CC, Efebera YA, et al. A feasibility study of electronic geriatric assessment for real-time morbidity evaluation. J Clin Oncol. 2016;34. https://doi.org/10.1200/JCO.2016.34.15_suppl.e21523. Electronic geriatric assessment is feasible in patients with hematologic malignancies.
- 38.• McCleary NJ, Wigler D, Berry D, et al. Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy. Oncologist. 2013;18:64–72. Computer-based geriatric assessment is feasible in patients with gastrointestinal cancer, but half required resistance completing the assessment. CrossRefPubMedPubMedCentralGoogle Scholar
- 39.•• Shahrokni A, Tin A, Downey RJ, Strong V, Mahmoudzadeh S, Boparai MK, et al. Electronic rapid fitness assessment: a novel tool for preoperative evaluation of the geriatric oncology patient. J Natl Compr Cancer Netw. 2017;15:172–9. Electronic geriatric assessment integrated with the electronic medical record is feasible. Google Scholar
- 40.Nathwani N, Mohile SG, Lipe B, Carig K, DiGiovanni L, Davis A, et al. Integrating a touchscreen-based brief geriatric assessment in older adults with multiple myeloma. J Clin Oncol. 2017;35:e21703–3.Google Scholar
- 41.Horgan AM, Seruga B, Pond GR, Alibhai SM, Amir E, De Wit R, et al. Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial. J Geriatr Oncol. 2014;5(2):119–26. https://doi.org/10.1016/j.jgo.2013.12.001.
- 42.Muss HB, Berry DA, Cirrincione C, Budman DR, Henderson IC, Citron ML, et al. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer And Leukemia Group B experience. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25:3699–704.Google Scholar
- 43.• Stinchcombe TE, Zhang Y, Vokes EE, et al. Pooled analysis of individual patient data on concurrent chemoradiotherapy for stage III non-small-cell lung cancer in elderly patients compared with younger patients who participated in US National Cancer Institute cooperative group studies. J Clin Oncol Off J Am Soc Clin Oncol. 2017; https://doi.org/10.1200/JCO.2016.71.4758. Older adults with cancer derived benefits from treatment but experienced increased toxicity.
- 44.Quoix E, Zalcman G, Oster J-P, Westeel V, Pichon E, Lavolé A, et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet Lond Engl. 2011;378(9796):1079–88. https://doi.org/10.1016/S0140-6736(11)60780-0.
- 46.Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993;119(2):121–6. https://doi.org/10.7326/0003-4819-119-2-199307150-00005.CrossRefGoogle Scholar
- 47.Jensen RE, Snyder CF, Abernethy AP, Basch E, Potosky AL, Roberts AC, et al. Review of electronic patient-reported outcomes systems used in cancer clinical care. J Oncol Pract. 2014;10:e215–e222.Google Scholar
- 48.•• Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2015; https://doi.org/10.1200/JCO.2015.63.0830. Electronic symptom monitoring improved health-related quality of life, reduced emergency room visits, and reduced hospitalizations.
- 49.•• Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017; https://doi.org/10.1001/jama.2017.7156. Electronic symptom monitoring improved overall survival.
- 50.Kearney N, McCann L, Norrie J, Taylor L, Gray P, McGee-Lennon M, et al. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2009;17:437–44.Google Scholar
- 51.McCann L, Maguire R, Miller M, Kearney N. Patients’ perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS) to monitor and manage chemotherapy related toxicity. Eur J Cancer Care (Engl). 2009;18(2):156–64. https://doi.org/10.1111/j.1365-2354.2008.00938.x.CrossRefGoogle Scholar
- 52.Maguire R, Fox PA, McCann L, Miaskowski C, Kotronoulas G, Miller M, et al. The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer. BMJ Open. 2017;7(5):e015016. https://doi.org/10.1136/bmjopen-2016-015016.
- 53.Increased use of oral chemotherapy drugs spurs increased attention to patient compliance. J Oncol Pract. 2008;4:175–7. https://doi.org/10.1200/JOP.0843002.
- 54.Ziller V, Kalder M, Albert U-S, Holzhauer W, Ziller M, Wagner U, et al. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol Off J Eur Soc Med Oncol. 2009;20:431–6.Google Scholar
- 55.Greer JA, Amoyal N, Nisotel L, Fishbein JN, MacDonald J, Stagl J, et al. A systematic review of adherence to oral antineoplastic therapies. Oncologist. 2016;21(3):354–76. https://doi.org/10.1634/theoncologist.2015-0405.
- 56.•• Puts MTE, Tapscott B, Fitch M, Howell D, Monette J, Wan-Chow-Wah D, et al. A systematic review of factors influencing older adults’ decision to accept or decline cancer treatment. Cancer Treat Rev. 2015;41:197–215. Adherence rates to cancer treatment vary across patients. Google Scholar
- 57.Stilley CS, Bender CM, Dunbar-Jacob J, Sereika S, Ryan CM. The impact of cognitive function on medication management: three studies. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2010;29:50–5.Google Scholar
- 58.• Loh KP, Pandya C, Zittel J, et al. Associations of sleep disturbance with physical function and cognition in older adults with cancer. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2017; https://doi.org/10.1007/s00520-017-3724-6. Almost 50% of patients referred to a geriatric oncology were screened positive for cognitive impairment.
- 59.Bennett JA, Cameron LD, Whitehead LC, Porter D. Differences between older and younger cancer survivors in seeking cancer information and using complementary/alternative medicine. J Gen Intern Med. 2009;24(10):1089–94. https://doi.org/10.1007/s11606-009-0979-8.CrossRefPubMedPubMedCentralGoogle Scholar
- 65.• Neugut AI, Zhong X, Wright JD, Accordino M, Yang J, Hershman DL. Nonadherence to medications for chronic conditions and nonadherence to adjuvant hormonal therapy in women with breast cancer. JAMA Oncol. 2016;2:1326–32. Nonadherence to chronic medications was associated with nonadherence to oral hormonal therapy. CrossRefPubMedGoogle Scholar
- 67.Hershman DL, Tsui J, Wright JD, Coromilas EJ, Tsai WY, Neugut AI. Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(9):1053–9. https://doi.org/10.1200/JCO.2014.58.3062.CrossRefGoogle Scholar
- 70.•• Mislang AR, Wildes TM, Kanesvaran R, Baldini C, Holmes HM, Nightingale G, et al. Adherence to oral cancer therapy in older adults: the International Society of Geriatric Oncology (SIOG) taskforce recommendations. Cancer Treat Rev. 2017;57:58–66. Recommendations from SIOG on adherence to oral cancer treatment. Google Scholar
- 73.Vitality - NantHealth. https://nanthealth.com/vitality/. Accessed 7 Sep 2017.
- 74.Improving medication adherence for oncology patients through high-tech interventions. In: Spec. Pharm. Times. https://www.specialtypharmacytimes.com/publications/specialty-pharmacy-times/2015/june-2015/improving-medication-adherence-for-oncology-patients-through-high-tech-interventions. Accessed 7 Sep 2017.
- 76.• Evans J, Papadopoulos A, Silvers CT, Charness N, Boot WR, Schlachta-Fairchild L, et al. Remote health monitoring for older adults and those with heart failure: adherence and system usability. Telemed J E Health. 2016;22:480–8. A number of issues specific to older adults were identified when studying technology use in this population. Google Scholar